UROGENITAL PROLAPSE AND URINARY INCONTINENCE
Conditions
Interventions
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: Chinese women who had presented with pelvic organ prolapse or urinary incontinence to our urogynaecology clinic during 2010-2019, additional 1600 cases with data available in Clinical Medical System (CMS), retrieval through Electronic Patient Record (ePR) system, including presenting symptoms, past obstetrics and gynaecological history, medical history and physical examination at first consultation and symptoms, including complication from the treatment and physical examination are also evaluated disregarding the management they received in follow-up.
Exclusion criteria
Exclusion criteria: No data available in Clinical Medical System (CMS).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical outcome of different types of non-surgical treatments and surgeries in patients with; | — |
Secondary
| Measure | Time frame |
|---|---|
| Underlying factors affecting the outcome of treatments in patients with pelvic organ prolapse; | — |
Countries
China
Contacts
The Chinese University of Hong Kong